AHR vs VTR: How American Healthcare REIT and Ventas Compare (2026)
Last updated August 2026
Short answer
VTR is the larger of the two ($47.97B market cap): the incumbent the market prices for continued execution (114.50x forward earnings, beta 0.72). AHR is the smaller challenger ($10.70B), cheaper on forward earnings (64.53x): more room to run, but more to prove. The real question is which set of drivers you believe, and whether owning one (or both) leaves you over-concentrated.
AHR vs VTR: the tie-breaker metrics
Same yardstick, side by side (as of August 2026). Valuation lined up like this is most meaningful for two names in the same corner of the market, which these are. Figures are approximate; verify before investing.
| Metric | AHR | VTR | What it tells you |
|---|---|---|---|
| Market cap | $10.70B | $47.97B | Size. The larger name is the incumbent; the smaller has more room to grow and more to prove. |
| Forward P/E | 64.53 | 114.50 | Valuation on next year's expected earnings, the same yardstick for both. Lower is cheaper for that growth; higher means the market is paying up. |
| Trailing P/E | 94.07 | 170.02 | Valuation on the last 12 months. A big drop from trailing to forward means the market expects earnings to jump, so more growth is already in the price. |
| Beta | 0.77 | 0.72 | Volatility vs the market. Above 1 swings harder than the index; below 1 is steadier. Higher beta means bigger drawdowns to hold through. |
| Price vs 52-week range | 83% of range | 77% of range | Where today's price sits between the 52-week low and high. Near the high is momentum with less margin of safety; near the low is out of favor or a discount, depending on why. |
| Price / book | 3.03 | 3.27 | How much you pay over book value. Very high can signal an asset-light, high-return business or a rich price. |
Reading it: AHR is the cheaper of the two on forward earnings, but cheaper is not the same as better. Pair the valuation with growth (how far the forward P/E sits below the trailing P/E) and risk (beta) before you decide.
Before you buy: how AHR and VTR affect your concentration
The metrics above tell you which is the marginally better business. The bigger risk for most people is not picking the slightly worse stock, it is over-concentrating. AHR and VTR share themes, so owning both, or adding either to what you already hold, can quietly push a large share of your portfolio into one bet.
This is the part a generic comparison page cannot answer, because it depends on what you own. Connect your brokerage and Walnut shows your real, combined AHR and VTR exposure, flags overlap with your existing positions, and tells you if adding one would tip you past a concentration you are comfortable with, read-only by default, with your login staying at your broker. Walnut is not an investment adviser.
What does American Healthcare REIT (AHR) do?
American Healthcare REIT owns and operates a diversified clinical healthcare property portfolio across the United States, the United Kingdom and the Isle of Man. It reports in four segments: integrated senior health campuses (ISHC, essentially the Trilogy Health Services platform of 130-plus combined senior living and skilled nursing campuses in Ohio, Kentucky, Indiana, Michigan and Wisconsin), senior housing operating properties (SHOP), outpatient medical buildings, and triple-net leased facilities. ISHC and SHOP together produce the large majority of net operating income, which is the single most important fact about the company: those are RIDEA-style structures where AHR receives the property's operating profit after staffing, food and insurance costs, not a fixed rent check. AHR became sole owner of Trilogy REIT Holdings in September 2024 after buying out the remaining 24% minority interest, which concentrated the earnings power (and the operating risk) inside the company.
What does Ventas (VTR) do?
Ventas, Inc. is an S&P 500 healthcare real estate investment trust that owns roughly 1,400 properties across North America and the United Kingdom, spanning senior housing communities, outpatient medical buildings, and research and lab (life science) assets. Its defining shift has been toward its senior housing operating portfolio (SHOP), which now accounts for more than half of net operating income and gives Ventas direct exposure to occupancy, rate, and margin trends rather than just fixed lease income. The company owns over 850 senior housing communities, and management has leaned hard into buying them, raising 2026 investment guidance to about $3 billion because acquiring communities has looked more attractive than building.
AHR vs VTR: how do they differ?
Both fit overlapping themes, but they are not interchangeable. The useful comparison is which set of drivers and risks you want exposure to.
- AHR drivers: The 80-plus demographic wave meeting a supply drought; Operating leverage in the RIDEA and Trilogy platforms.
- VTR drivers: Senior housing (SHOP) demographic tailwind; Capital deployment into acquisitions.
Which fits which kind of investor
A faster-growing, richer-valued name usually swings harder, so it suits a longer horizon and a higher tolerance for volatility; a steadier, more cash-generative business suits a more conservative or income-minded investor. The honest test is which set of risks you could hold through a drawdown: The same RIDEA structure that creates the upside removes the cushion on the way down: if occupancy stalls or wage and insurance inflation reaccelerate, NOI falls straight to the bottom line with no lease floor underneath it. For VTR, as an operating (SHOP-heavy) REIT, Ventas carries more earnings variability than a pure net-lease landlord because occupancy, labor costs, and rate growth flow straight to NOI.
AHR or VTR: which should you pick?
Growth-minded investors who believe the theme has years to run tend to accept the richer multiple for more upside; value-minded investors lean toward the cheaper forward earnings and steadier profile. Pick AHR if you believe its drivers more; VTR if you believe its. Many investors hold both, but since they share themes, that is a concentrated bet, not diversification. Decide deliberately and check overlap. For the full detail, see the AHR and VTR guides.
AHR vs VTR: the full fundamentals
AHR. For a REIT, FFO and AFFO matter more than reported EPS because large non-cash depreciation charges push GAAP net income far below actual cash generation, which is why AHR's headline P/E near 90 looks nothing like its high-20s multiple of normalized FFO. The multiple is still a premium to the healthcare REIT group, and the market is effectively underwriting several more years of the double-digit same-store NOI growth AHR has delivered for nine straight quarters. The unusual feature versus most REITs is the yield: under 2% means this is being priced as a growth equity rather than an income holding.
VTR. VTR trades around $96 with a market cap near $47 billion, making it the second-largest healthcare REIT behind Welltower. At roughly a mid-20s price-to-FFO multiple, the market is paying up for a fifth consecutive year of double-digit senior housing NOI growth. The dividend yield is modest for a REIT at about 2.1%, reflecting both the growth premium and a payout that management has been rebuilding since the pandemic.
Headline figures (approximate, August 2026): AHR shows revenue (ttm) ~$2.37B, up ~12.7% year over year, 2026 normalized ffo guidance ~$2.03 to $2.09 per diluted share (Q1 2026 NFFO was ~$0.50, up over 30%), same-store noi growth ~12.1% in Q1 2026; full-year 2026 guidance ~9.0% to 12.0%, dividend ~$1.00 annualized ($0.25 quarterly), ~1.8% yield; VTR shows revenue (ttm) ~$5.7B, q1 2026 revenue ~$1.66B, normalized ffo/share (q1 2026) ~$0.94, 2026 ffo/share guidance ~$3.82-$3.89.
The bottom line: AHR vs VTR
AHR and VTR are related but distinct: same themes, different businesses and risks. Neither wins in the abstract; the right pick is whichever thesis you actually believe, sized so you are not over-concentrated in one theme. Walnut can show your combined AHR and VTR exposure against your real portfolio. It is not an investment adviser.
Wondering how AHR or VTR fits the portfolio you already own? Walnut is an AI investing app that connects your brokerage read-only and answers questions like that about your actual holdings: overlap, concentration, and how each position tracks the S&P 500. Compare the best AI portfolio analyzers or see the best AI investing apps in 2026.
Investing in American Healthcare REIT with AI
Connect the broker you already use and ask Walnut's AI how AHR fits what you actually hold: whether you own it already through a fund, what it would do to your concentration, and how it has tracked the S&P 500. Read-only by default, and you approve anything before it reaches your broker.
FAQ
What is the difference between AHR and VTR?
+
American Healthcare REIT owns and operates a diversified clinical healthcare property portfolio across the United States, the United Kingdom and the Isle of Man. Ventas, Inc. They show up together because they share investment themes, but they are different businesses, so the better fit depends on which thesis you are expressing.
Is AHR or VTR the better stock?
+
Neither is universally better. VTR is the larger incumbent; AHR is the smaller challenger and looks cheaper on forward earnings. Walnut is informational, not investment advice. Compare what each does, the tie-breaker metrics above, and the risks, then decide which fits your thesis and what you already own.
Which is cheaper, AHR or VTR?
+
On forward P/E (as of August 2026), AHR trades at 64.53x and VTR at 114.50x, so AHR is the cheaper of the two on next year's expected earnings. A lower multiple is not automatically the better buy: a richer valuation can be justified by faster growth, and a lower one can reflect real risk. Weigh the multiple against how fast each business is compounding.
Should you own both AHR and VTR?
+
Because they share themes, owning both concentrates you in that theme. That can be intentional (a focused bet) or accidental (less diversification than it looks). Walnut can show your combined exposure across both, and whether adding either over-concentrates you, before you buy.
What are the risks of AHR vs VTR?
+
AHR: The same RIDEA structure that creates the upside removes the cushion on the way down: if occupancy stalls or wage and insurance inflation reaccelerate, NOI falls straight to the bottom line with no lease floor underneath it. Skilled nursing and the ISHC segment carry meaningful Medicare and Medicaid reimbursement exposure, so federal or state rate decisions and any tightening of Medicaid funding are genuine earnings risks that AHR does not control. Valuation is its own risk factor: at roughly 27 times 2026 NFFO guidance and a GAAP P/E in the high 80s, the shares leave little room for a guidance miss, and the sub-2% dividend yield offers little support if the growth narrative cools. Concentration matters too, with the Trilogy platform in five Midwestern states responsible for a large share of portfolio NOI. Finally, as a heavily acquisitive REIT, AHR depends on continued access to equity and debt on favorable terms, and a change in rates or sentiment toward senior housing would make the external growth engine much more expensive to run. VTR: As an operating (SHOP-heavy) REIT, Ventas carries more earnings variability than a pure net-lease landlord because occupancy, labor costs, and rate growth flow straight to NOI. A premium FFO multiple (roughly mid-20s price-to-FFO) leaves little room for disappointment if senior housing growth decelerates or supply eventually catches up. Interest rates matter twice: higher rates raise the cost of the debt REITs rely on and can pressure REIT valuations broadly. Large ongoing acquisitions carry integration and pricing risk, and any renewed pressure on senior housing occupancy (from a health event or weaker demand) would hit results directly. Life science and outpatient medical demand can also soften with tenant budgets.
Walnut is informational, not investment advice. This page is descriptive and not a recommendation to buy or sell AHR or VTR; figures are approximate and dated (as of August 2026). Verify current data before investing.